Atlas FDA

Predicate Research Report · generated 2026-08-22 · Print / save as PDF · Save to account

Sterling Drug, Inc. · Predicate Candidate Screening

9 FDA 510(k) clearances under this manufacturer; the 50 most recent screened below.

47 daysmedian FDA review time
86 days90th percentile
9clearances measured
K-numberDeviceApplicantDecidedReview daysRecalls (K-match)
K901369GREEN LABEL BIOBRANE II AND RED LABEL BIOBRANE IISterling Drug, Inc.1990-06-05740
K896110BIOBRANE(R) IISterling Drug, Inc.1989-11-28360
K875275WINTHROP PHARMACEUTICALS CONTRAST MEDIA WARMERSterling Drug, Inc.1988-01-27340
K840260PERIOGRAF DURAPATITE 40-60 MESHSterling Drug, Inc.1984-04-05860
K820164EMPTY STERILE CARPUJECTSterling Drug, Inc.1982-02-24350
K820023CONAGRAF TM DURAPATITE CONESSterling Drug, Inc.1982-02-24500
K813257ALVEOGRAF DURAPATITE(18-40 MESH)Sterling Drug, Inc.1982-01-05470
K813070PERIOGRAFSterling Drug, Inc.1981-11-20180
K780209DILUTION SPIKESterling Drug, Inc.1978-04-10630

Methodology

Recall counts reflect FDA recall records explicitly referencing each K-number; FDA links recalls to K-numbers inconsistently, so 0 means "none found in FDA records," not "never recalled." Data: FDA openFDA, refreshed weekly. Verify decisions of consequence against the primary source. Full candidate set and CSV export: atlasbyauro.com.

Prepared with Atlas

Predicate research, review-time statistics and recall monitoring for 510(k) teams: atlasbyauro.com/fda